Horizon 2020 evaluation highlights benefit of cross-border research but points to areas for improvement
Lancet Oncol
.
2024 Mar;25(3):282-283.
doi: 10.1016/S1470-2045(24)00086-X.
Epub 2024 Feb 8.
Author
Emma Wilkinson
PMID:
38342114
DOI:
10.1016/S1470-2045(24)00086-X
No abstract available